Home/ Crypto News/ BioMarin (BMRN) Stock Secures Victory in Patent Dispute, Gains Royalty Stream Through 2030

blockonomi Aug 31, 2026

BioMarin (BMRN) Stock Secures Victory in Patent Dispute, Gains Royalty Stream Through 2030

Stocks

BioMarin (BMRN) stock adds royalty revenue after patent settlement with Ascendis Pharma over CNP technology, securing payments through May 2030.

The post BioMarin (BMRN) Stock Secures Victory in Patent Dispute, Gains Royalty Stream Through 2030 appeared first on Blockonomi.

Source: Source: Blockonomi